Skip to content

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04092387
Enrollment
326
Registered
2019-09-17
Start date
2020-10-18
Completion date
2023-11-27
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Keywords

Biomarkers of Exposure, Nicotine Dependence, Reduced Nicotine Cigarettes, Tobacco Withdrawal, Women, Health Disparities, Vulnerable Populations, E-Cigarettes

Brief summary

Despite marked reductions in cigarette smoking in the general population, smoking among economically disadvantaged women has increased. Smoking among women of reproductive age is a particular concern because in addition to the usual health risks, there are additional risks should they become pregnant. A national nicotine reduction policy for cigarettes has considerable potential to reduce tobacco use, dependence, and improve health in this population. Controlled trials in general population samples have demonstrated that reducing the nicotine content in cigarettes can reduce cigarettes per day (CPD), dependence severity, and tobacco toxicant exposure. The goal of the proposed trial is to experimentally examine whether increasing the availability and appeal of an alternative, non-combusted source of nicotine (e-cigarettes) enhances the effect of altering the nicotine in cigarettes in non-pregnant female cigarette smokers of childbearing age. Additionally, investigators will test whether allowing participants to personalize the flavor of the e-liquid alters any moderating effects their availability may have on tobacco cigarette smoking. Daily smokers who are female, aged 21-44 years, and have a maximum educational attainment of graduating high school, will be recruited at Johns Hopkins University and the University of Vermont. Investigators will study two research cigarettes referred to here as Research Cigarettes 1 (RC1) and Research Cigarettes 2 (RC2). One will be a normal nicotine content cigarette and the other a reduced nicotine content cigarette. Investigators will study two e-cigarette conditions referred to here as E-Cigarette Condition 1 (EC1) and E-Cigarette Condition 2 (EC2). Both e-cigarette conditions will involve the same commercially available devices and same nicotine-containing e-liquid, but in one condition that e-liquid will be available only in tobacco flavor while in the other the e-liquid will be available in multiple flavors from which participants can choose three based on personal preference. Participants will be assigned to one of the following four conditions: (1) RC1 only; (2) RC2 only; (3) RC2 + EC1; (4) RC2 + EC2. Participants will be asked to use only their assigned study products for 16 weeks. Outcome measures include total CPD, craving, withdrawal, psychiatric symptoms, breath carbon monoxide (CO), other biomarkers of tobacco toxicant exposure, and cigarette demand assessed by behavioral economic purchase tasks.

Interventions

1\) Altering the nicotine content of the tobacco research cigarettes

Comparing effects of combining RC2 with EC 1 versus EC2

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Food and Drug Administration (FDA)
CollaboratorFED
Johns Hopkins University
CollaboratorOTHER
University of Vermont
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Double blind dosing of tobacco cigarette nicotine content levels.

Intervention model description

Randomized parallel groups research design.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * 21 to 44 years old

Exclusion criteria

* Male * Under 21 years old * Over 44 years old

Design outcomes

Primary

MeasureTime frameDescription
Number of Cigarettes Smoked Per Day16 weeksCigarettes per day will be assessed for use of cigarettes with different nicotine content.

Countries

United States

Participant flow

Participants by arm

ArmCount
RC 1 Only
Research cigarettes #1 Varying the nicotine content of cigarettes: 1) Altering the nicotine content of the tobacco research cigarettes
83
RC 2 Only
Research Cigarettes #2 Varying the nicotine content of cigarettes: 1) Altering the nicotine content of the tobacco research cigarettes
85
RC 2 + EC 1
Research Cigarettes #2 plus E-cigarettes #1 Varying the nicotine content of cigarettes: 1) Altering the nicotine content of the tobacco research cigarettes E-Cigarettes: Comparing effects of combining RC2 with EC 1 versus EC2
74
RC 2 + EC 2
Research Cigarettes #2 plus E-cigarettes #2 Varying the nicotine content of cigarettes: 1) Altering the nicotine content of the tobacco research cigarettes E-Cigarettes: Comparing effects of combining RC2 with EC 1 versus EC2
84
Total326

Baseline characteristics

CharacteristicRC 1 OnlyRC 2 OnlyRC 2 + EC 1RC 2 + EC 2Total
Age, Continuous39.77 years
STANDARD_DEVIATION 10.98
39.85 years
STANDARD_DEVIATION 9.28
41.51 years
STANDARD_DEVIATION 12.39
39.38 years
STANDARD_DEVIATION 10.59
40.09 years
STANDARD_DEVIATION 10.79
Age started smoking regularly16.61 years
STANDARD_DEVIATION 3.97
15.92 years
STANDARD_DEVIATION 3.91
16.24 years
STANDARD_DEVIATION 3.84
16.79 years
STANDARD_DEVIATION 5.15
16.39 years
STANDARD_DEVIATION 4.26
Breath CO level20.90 ppm
STANDARD_DEVIATION 14.02
19.30 ppm
STANDARD_DEVIATION 12.39
21.03 ppm
STANDARD_DEVIATION 13.38
20.66 ppm
STANDARD_DEVIATION 13.44
20.46 ppm
STANDARD_DEVIATION 13.28
Cigarettes smoked per day16.42 cigarettes per day
STANDARD_DEVIATION 8.02
18.44 cigarettes per day
STANDARD_DEVIATION 9.47
17.86 cigarettes per day
STANDARD_DEVIATION 9.11
16.90 cigarettes per day
STANDARD_DEVIATION 8.85
17.40 cigarettes per day
STANDARD_DEVIATION 8.87
Educational level
Associate's degree
8 Participants11 Participants13 Participants11 Participants43 Participants
Educational level
≥College graduate
15 Participants13 Participants12 Participants12 Participants52 Participants
Educational level
<High school
9 Participants4 Participants3 Participants14 Participants30 Participants
Educational level
High school graduate, equivalency, or some college
51 Participants57 Participants46 Participants47 Participants201 Participants
FTND score5.12 scores on a scale
STANDARD_DEVIATION 2.24
5.31 scores on a scale
STANDARD_DEVIATION 2.2
5.26 scores on a scale
STANDARD_DEVIATION 2.31
4.70 scores on a scale
STANDARD_DEVIATION 2.07
5.09 scores on a scale
STANDARD_DEVIATION 2.21
Marital status
Divorced, separated, or widowed
26 Participants23 Participants21 Participants25 Participants95 Participants
Marital status
Married
8 Participants15 Participants17 Participants11 Participants51 Participants
Marital status
Never married
49 Participants47 Participants36 Participants48 Participants180 Participants
Population
Affective disorders
44 Participants43 Participants41 Participants44 Participants172 Participants
Population
Females with lower educational level
20 Participants23 Participants16 Participants21 Participants80 Participants
Population
OUD
19 Participants19 Participants17 Participants19 Participants74 Participants
Primarily smokes mentholated cigarettes32 Participants35 Participants31 Participants33 Participants131 Participants
Race/Ethnicity, Customized
Black, non-Latino
9 Participants6 Participants9 Participants9 Participants33 Participants
Race/Ethnicity, Customized
Latino
4 Participants3 Participants3 Participants2 Participants12 Participants
Race/Ethnicity, Customized
Non-Latino other or multiracial
4 Participants8 Participants2 Participants5 Participants19 Participants
Race/Ethnicity, Customized
White, non-Latino
66 Participants68 Participants60 Participants68 Participants262 Participants
Region of Enrollment
United States
83 participants85 participants74 participants84 participants326 participants
Sex: Female, Male
Female
65 Participants69 Participants50 Participants59 Participants243 Participants
Sex: Female, Male
Male
18 Participants16 Participants24 Participants25 Participants83 Participants
Urine cotinine level4499.25 ng/mL
STANDARD_DEVIATION 3120.2
5235.67 ng/mL
STANDARD_DEVIATION 3251.28
5156.57 ng/mL
STANDARD_DEVIATION 4150.44
5293.33 ng/mL
STANDARD_DEVIATION 3799.45
5043.55 ng/mL
STANDARD_DEVIATION 3680.12
Used e-cigarettes, past 30 days13 Participants11 Participants5 Participants13 Participants42 Participants
Used other tobacco products, past 30 days5 Participants4 Participants5 Participants9 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 830 / 851 / 740 / 84
other
Total, other adverse events
71 / 8374 / 8562 / 7472 / 84
serious
Total, serious adverse events
9 / 834 / 854 / 742 / 84

Outcome results

Primary

Number of Cigarettes Smoked Per Day

Cigarettes per day will be assessed for use of cigarettes with different nicotine content.

Time frame: 16 weeks

Population: Participants who completed week 16 of study

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
RC 1 OnlyNumber of Cigarettes Smoked Per Day22.54 cigarettes per dayStandard Error 1.59
RC 2 OnlyNumber of Cigarettes Smoked Per Day14.32 cigarettes per dayStandard Error 1.32
RC 2 + EC 1Number of Cigarettes Smoked Per Day11.76 cigarettes per dayStandard Error 1.18
RC 2 + EC 2Number of Cigarettes Smoked Per Day7.63 cigarettes per dayStandard Error 0.9

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026